Interestingly, one study found TP53 mutations in gliosarcoma to be correlated with worse prognosis, treatment resistance, and epithelial to mesenchymal transition of the sarcomatous cell population, making it a prospective marker for prognostic categorization1. The gene discussed is TP53; the disease is gliosarcoma.